Smith C G, Asch R H
NIDA Res Monogr. 1984;44:82-96.
Studies with laboratory animals clearly show that the crude drug marijuana and delta-9-THC, the principal psychoactive ingredient, inhibit secretion of the pituitary hormones LH and FSH as well as prolactin. These changes in pituitary hormone levels produce decreases in sex steroid hormones and cause disruption of ovulation and spermatogenesis. With chronic drug use, disruption of sex accessory organs has also been observed. A principal site of THC action is the hypothalamus, because THC effects on pituitary hormone production can be reversed with hypothalamic releasing factors. It is now known that drug effects in sexually mature animals are reversible when drug treatment stops. In adults, tolerance develops to hormone changes brought on by the use of marijuana. Clinical studies on human subjects generally agree with the animal findings, although conflicting results have been reported as well. It is likely that the differences in results obtained in experiments with laboratory animals and with humans are caused, at least in part, by differences in experimental design. Further, it is not known how much disruption of reproductive hormone levels is necessary for changes in human fertility and sexual function to occur. The use of marijuana by pregnant women or by women who are attempting to become pregnant is cause for special concern. Studies with laboratory animals and retrospective studies on women who have used marijuana during pregnancy show that the risks of pregnancy loss and other adverse effects on the fetus are increased by marijuana use. THC crosses the placental barrier and while the potent teratogenic and mutagenic effects suggested for marijuana some years ago have not been confirmed, significant changes consistent with retardation of fetal growth and development have been observed. Effects of THC on the proper functioning of the placenta may be responsible for these effects on pregnancy. Pregnancy that occurs after the development of tolerance with chronic marijuana use may involve an ovum that has been damaged by exposure to the drug during critical developmental stages. More studies need to be done before the mechanisms of toxic effects on pregnancy and fetal development can be described. While there have been no clinical studies relating marijuana use to adolescent development, studies in laboratory animals show that the developing reproductive system during adolescence is particularly vulnerable.(ABSTRACT TRUNCATED AT 400 WORDS)
对实验动物的研究清楚地表明,天然药物大麻及其主要精神活性成分Δ⁹ - 四氢大麻酚会抑制垂体激素促黄体生成素(LH)、促卵泡生成素(FSH)以及催乳素的分泌。垂体激素水平的这些变化会导致性类固醇激素减少,并引起排卵和精子发生的紊乱。长期使用该药物还会观察到性附属器官的破坏。四氢大麻酚的主要作用部位是下丘脑,因为四氢大麻酚对垂体激素产生的影响可通过下丘脑释放因子逆转。现在已知,当停止药物治疗时,性成熟动物的药物作用是可逆的。在成年人中,对使用大麻引起的激素变化会产生耐受性。对人类受试者的临床研究总体上与动物研究结果一致,不过也有相互矛盾的报道。实验动物和人类实验结果的差异很可能至少部分是由实验设计的差异造成的。此外,尚不清楚生殖激素水平的多大程度的破坏会导致人类生育能力和性功能的变化。孕妇或试图怀孕的女性使用大麻尤其令人担忧。对实验动物的研究以及对孕期使用过大麻的女性的回顾性研究表明,使用大麻会增加流产风险以及对胎儿的其他不良影响。四氢大麻酚会穿过胎盘屏障,虽然几年前认为大麻具有的强致畸和致突变作用尚未得到证实,但已观察到与胎儿生长发育迟缓一致的显著变化。四氢大麻酚对胎盘正常功能的影响可能是这些对妊娠的影响的原因。在长期使用大麻产生耐受性后发生的妊娠,可能涉及一个在关键发育阶段因接触该药物而受损的卵子。在能够描述对妊娠和胎儿发育的毒性作用机制之前,还需要进行更多研究。虽然尚无关于使用大麻与青少年发育关系的临床研究,但实验动物研究表明,青春期发育中的生殖系统特别脆弱。(摘要截取自400字)